The Ethical & Legal Complexities: To what extent should marketing for Medical Cannabis be allowed?

The new CanG law has opened the floodgates for proactive
marketing towards new cannabis patients. Prescriptions are now
available starting from 1€, necessary consultations and the
shipping of medical cannabis take place entirely online, and
rappers are promoting the whole thing. Is this in the interests
of healthcare and patients? What do healthcare professionals and
pharmaceutical companies say about this? And what is the position
of the companies involved?

Moderator



Bertan Türemis



Speakers



Marla Luther


Niels Lutzhoeft


Gero Kohlhaas


Matthias Fischer


Janosch W. Kratz